Medical Digest & Congress Report

Επεισόδια

• 
  Control the modifiable risk factors to prevent dementia: Insights from the 10/66 studies 28.07.2026 8λ

  Professor Daisy Acosta delivers an essential expert overview on the shifting landscape of dementia prevalence across Latin America, building on crucial insights from the 10/66 studies. This concise brief highlights the unexpected increase in dementia prevalence over the past two decades across multiple catchment sites, contrasting sharply with the declining trends observed in high-income countries. Professor Acosta underscores the growing and uneven burden facing the region, outlining a critical roadmap that emphasizes the urgent need for strengthened surveillance, targeted risk reduction strategies, and substantial infrastructure investment to control modifiable risk factors and prevent dementia before it overwhelms healthcare systems.Video: https://medicaldigest.org/scientific-contents/interview:control-modifiable-risk-factors-prevent-dementia-insights-1066-studies
• 
  The New Landscape of Alzheimer’s Therapy: Targets, Treatments, and Future Outlook 22.07.2026 13λ

  Professor Takaomi C. Saido, world renowned scientist, delivers a comprehensive expert overview on the current state of Alzheimer's disease research, moving past traditional models to explore groundbreaking therapeutic targets. This concise brief highlights the mechanisms behind approved disease-modifying therapies, the crucial role of neprilysin and somatostatin receptor in amyloid clearance, and the development of next-generation knock-in mouse models mapping the complex amyloid-tau pathology pathways. Professor Saido outlines a visionary roadmap toward preventing Alzheimer's before the clinical onset of cognitive impairment.Video: https://medicaldigest.org/scientific-contents/interview:new-landscape-alzheimers-therapy-targets-treatments-and-future-outlook
• 
  Highlights of ISTH Guidelines and Guidance Documents - report from ISTH 2026 21.07.2026 6λ

  Dr. James Douketis delivers an essential overview of the key highlights from the newly updated ISTH guidelines and guidance documents at the ISTH 2026 Congress. This targeted brief focuses on practical, evidence-based clinical recommendations, highlighting two major clinical updates:Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery – A refined, three-tier classification framework to optimize periprocedural anticoagulation management.Monitoring and Management of Therapeutic-dose UFH in Practice – Key updates on standardizing and improving the safety of therapeutic unfractionated heparin (UFH) dosing and monitoring.Video: https://medicaldigest.org/scientific-contents/interview:highlights-isth-guidelines-and-guidance-documents
• 
  Updated recommendations on the diagnosis and classification of FXIII deficiencies / ISTH 2026 Diagnostic Highlights 21.07.2026 4λ

  Dr. Zsuzsanna Bagoly presents the highly anticipated updated clinical recommendations for the diagnosis and classification of Factor XIII (FXIII) deficiencies at the ISTH 2026 Congress. This essential brief outlines the revised diagnostic algorithms, standardized laboratory assays, and clear classification pathways designed to improve the detection and management of this underdiagnosed, life-threatening bleeding disorder.Video: https://medicaldigest.org/scientific-contents/interview:updated-recommendations-diagnosis-and-classification-fxiii-deficiencies-isth-2026-diagnostic-highlights
• 
  Future Anticoagulants - report from ISTH 2026 21.07.2026 5λ

  Dr. Marco Donadini highlights the next generation of antithrombotic therapies at the ISTH 2026 Congress, featuring these breakthrough presentations:- A Synthetic, Allosteric, Highly Selective, Reversible Inhibitor of Human Factor XIa for Venous and Lung (Cancer-Associated) Thrombosis – Umesh Desai (Richmond, US)- EXocite ACTive site (EXACT) Inhibitors as Potent RNA Aptamer-Based Anticoagulants Targeting Various Coagulation Factors – Jeffrey Clancy (Durham, US)- Efficacy-Safety Paradox of Next-Gen Factor XI/XIa Inhibitors: Meta-Analysis of Phase 2 and 3 Trials – Rahul Falodia (Jodhpur, India)- BAY 3389934: A Dual Factor IIa/Xa Inhibitor – Nicole Juffermans (Rotterdam, The Netherlands)- REGN9533, a monoclonal antibody targeting Factor XII (FXII), Phase 1 study – Frédéric Vanhoutte (Antwerp, Belgium)Video: https://medicaldigest.org/scientific-contents/interview:future-anticoagulants
• 
  Anticoagulant Associated Bleeding: Specific Populations and Reversal - report from ISTH 2026 21.07.2026 6λ

  Dr. Kerstin de Wit highlights critical updates on anticoagulant-associated bleeding risks, management, and reversal strategies presented at the ISTH 2026 Congress, featuring the following key studies:- Perioperative Anticoagulation Management and Outcomes in Thrombotic Antiphospholipid Syndrome: A Single-Center Cohort Study – Miguel Paquette (Ottawa, Canada)- The Incidence and Outcomes of LMWH-Related ISTH defined Major Bleeding: A National Observational Cohort Study – Gwendoline Fuller (London, UK)- Validation of a Treatment Decision Pathway for Andexanet Alfa (VALIDA) – Jan Beyer-Westendorf (Dresden, Germany)- Reversal efficacy of novel single domain antibodies against rivaroxaban, edoxaban or apixaban in vitro and ex vivo: studying platelet-dependent clot formation under flow – Xiang Gui (Maastricht, The Netherlands)Video: https://medicaldigest.org/scientific-contents/interview:anticoagulant-associated-bleeding-specific-populations-and-reversal
• 
  Acute and Long-Term Management of Severe DVT by ESVM VTE Guideline - report from ISTH 2026 21.07.2026 6λ

  Dr. Oliver Schlager outlines the acute and long-term management of severe deep vein thrombosis (DVT) in alignment with the ESVM VTE Guidelines at the ISTH 2026 Congress. This brief highlights key recommendations for early intervention, tailored anticoagulation duration, and strategies to minimize the risk of post-thrombotic syndrome (PTS).Video: https://medicaldigest.org/scientific-contents/interview:acute-and-long-term-management-severe-dvt-esvm-vte-guideline
• 
  Introductions to the ISTH Guidelines and Guidance Documents - report from ISTH 2026 21.07.2026 5λ

  Dr. Fionnuala Ní Áinle presents an essential overview of the latest ISTH Guidelines and Guidance Documents at the ISTH 2026 Congress. This brief highlights key clinical recommendations, the methodological rigor behind the guidelines, and practical implementation strategies to standardize care in thrombosis and hemostasis globally.Video: https://medicaldigest.org/scientific-contents/interview:introductions-isth-guidelines-and-guidance-documents-report-isth-2026
• 
  Cancer-Associated Thrombosis & Hemostasis - report from ISTH 2026 21.07.2026 12λ

  Dr. Darko Antic presents key insights into the complex management of cancer-associated thrombosis (CAT) and hemostasis at the ISTH 2026 Congress. This brief highlights the latest clinical evidence on anticoagulation strategies, balancing bleeding versus recurrent thrombotic risks, and customizing treatment pathways for oncological patients.Video: https://medicaldigest.org/scientific-contents/interview:cancer-associated-thrombosis-hemostasis
• 
  VTE Diagnosis: What's New? - report from ISTH 2026 21.07.2026 8λ

  Dr. Aurélien Delluc highlights key advancements in Venous Thromboembolism (VTE) diagnosis from the ISTH 2026 Congress. Video: https://medicaldigest.org/scientific-contents/interview:vte-diagnosis-whats-new
• 
  Novelties in the Treatment of Alzheimer's Disease 21.07.2026 6λ

  Dr. Rebecca Edelmayer presents an inspiring overview of the latest breakthroughs and novelties in the treatment of Alzheimer's disease at the AAIC 2026 Congress.Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-alzheimers-disease
• 
  Highlights of the AAIC 2026 Congress 21.07.2026 13λ

  Dr. Courtney Kloske delivers a highly anticipated expert overview of the most impactful breakthroughs and scientific updates presented at the AAIC 2026 Congress. This concise brief highlights accelerated advances in early diagnostics, emerging multi-omics approaches, key clinical trial outcomes, and global initiatives shaping the future of Alzheimer's and dementia research.Video: https://medicaldigest.org/scientific-contents/interview:highlights-aaic-2026-congress
• 
  Targeting CD19+ B-Cells in IgG4-Related Disease: Clinical Evidence and Implications for Long-Term Management​ - Report from EULAR 2026 15.06.2026 15λ

  Dr. Emanuel Della Torre discusses the clinical evidence behind targeting CD19+ B-cells in IgG4-related disease in a post-congress interview following EULAR 2026. This recap focuses on the therapeutic impact of these strategies, underlying immunological mechanisms, and the long-term management implications for patients in clinical practice.Video: https://medicaldigest.org/scientific-contents/interview:targeting-cd19-b-cells-igg4-related-disease-clinical-evidence-and-implications-long-term-management
• 
  State-of-the-Art Treatment in Psoriatic Arthritis - Report from EULAR 2026 15.06.2026 23λ

  Professor Laura C. Coates highlights the rapidly evolving landscape of state-of-the-art treatments for psoriatic arthritis (PsA) in a post-congress interview following EULAR 2026. This recap focuses on personalized management pathways, novel targeted therapies, and strategic frameworks aimed at optimizing long-term patient outcomes.Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-psoriatic-arthritis
• 
  The RA Paradigm Shift: New Insights into Pathogenesis and a Pipeline of Promise - Report from EULAR 2026 15.06.2026 5λ

  Professor Elena Nikiphorou discusses the ongoing paradigm shift in rheumatoid arthritis (RA), presented at the EULAR 2026 Congress. This recap focuses on novel insights into RA pathogenesis and explores the promising therapeutic pipeline, highlighting how these scientific advancements are translating into more targeted, effective management strategies for clinical practice.Video: https://medicaldigest.org/scientific-contents/interview:ra-paradigm-shift-new-insights-pathogenesis-and-pipeline-promise
• 
  Systemic Sclerosis: Deciphering Pathogenesis, Unveiling Comorbidities, and Paving the Way for Targeted Treatment - Report from EULAR 2026 15.06.2026 10λ

  Professor Oliver Distler dives into the complex landscape of systemic sclerosis (SSc), presented at the EULAR 2026 Congress. This recap focuses on recent breakthroughs in deciphering SSc pathogenesis, identifying and managing critical comorbidities, and evaluating emerging therapeutic strategies that pave the way for highly targeted clinical treatments.Video: https://medicaldigest.org/scientific-contents/interview:systemic-sclerosis-deciphering-pathogenesis-unveiling-comorbidities-and-paving-way-targeted-treatment
• 
  EULAR / ACR Classification Criteria for Anti-Synthetase Syndrome - Report from EULAR 2026 15.06.2026 6λ

  Professor Lorenzo Cavagna discusses the developed EULAR / ACR classification criteria for anti-synthetase syndrome, presented at the EULAR 2026 Congress. This recap highlights the critical diagnostic parameters, clinical features, and serological markers involved in these standardized criteria, aiming to improve early recognition and harmonize research and patient care globally.Video: https://medicaldigest.org/scientific-contents/interview:eular-acr-classification-criteria-anti-synthetase-syndrome
• 
  Workflow in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026 15.06.2026 4λ

  Professor Annelies Boonen explores systemic workflows and their critical role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights optimized clinical pathways, health economics, and strategic workflow improvements designed to enhance patient care and sustainability on a global scale.Video: https://medicaldigest.org/scientific-contents/interview:workflow-focus-advancing-global-health-rheumatology
• 
  Diagnosing Osteoporosis in Inflammatory Rheumatic Conditions - Report from EULAR 2026 15.06.2026 6λ

  Professor Radmila Matijevic addresses the complexities of diagnosing osteoporosis within the context of inflammatory rheumatic conditions, presented at the EULAR 2026 Congress. This recap focuses on best practices for early identification, the impact of chronic inflammation on bone density, and diagnostic strategies to effectively assess fracture risk in this specific patient population.Video: https://medicaldigest.org/scientific-contents/interview:diagnosing-osteoporosis-inflammatory-rheumatic-conditions
• 
  Biosimilars in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026 15.06.2026 6λ

  Professor Tore K. Kvien explores the evolving landscape of biosimilars and their vital role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights clinical application, access strategies, and the overall impact of biosimilar therapies in improving patient outcomes and healthcare sustainability on a global scale.Video: https://medicaldigest.org/scientific-contents/interview:biosimilars-focus-advancing-global-health-rheumatology